|
Index of reports
> Cases with Pyrexia (104)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 104 Next >>
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Asthenia, Escherichia Infection, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Duoneb; Lovenox; Xanax; Benadryl; Metoprolol Tartrate; Vicodin; Protonix
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-22
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 300mg weekly
Indication: Breast Cancer
Start date: 2012-04-26
Doxorubicin Hydrochloride
Dosage: 29mg weekly
Indication: Breast Cancer
Start date: 2012-04-26
Lapatinib
Dosage: 750mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-04-26
Paclitaxel
Dosage: 117mg weekly
Indication: Breast Cancer
Start date: 2012-04-26
Trastuzumab
Dosage: 456mg every 3 weeks
Indication: Breast Cancer
Start date: 2012-04-26
Possible Paclitaxel side effects in 67 year old male
Reported by a consumer/non-health professional from Ireland on 2012-08-21
Patient: 67 year old male
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded: Ipilimumab
Indication: non-Small Cell Lung Cancer
Carboplatin
Indication: non-Small Cell Lung Cancer
Paclitaxel
Indication: non-Small Cell Lung Cancer
Placebo
Indication: non-Small Cell Lung Cancer
Possible Paclitaxel side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: 30 year old female, weighing 106.6 kg (234.5 pounds)
Reactions: Vomiting, Blood Potassium Decreased, Nausea, Diarrhoea, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: carboauc5
Indication: Endometrial Cancer
Start date: 2012-08-06
End date: 2012-08-06
Paclitaxel
Dosage: taxol 175mg/m2
Indication: Endometrial Cancer
Start date: 2012-08-07
End date: 2012-08-10
Ridaforolimus
Dosage: ridaforolimus 20mg po qd
Administration route: Oral
Indication: Endometrial Cancer
Start date: 2012-08-07
End date: 2012-08-10
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Pneumonia, Dyspnoea, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Lovenox; Xanax; Benadryl; Duoneb; Protonix; Metoprolol; Vicodin
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-10
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Hypocalcaemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: drug used: non pegylated liposomal doxorubicin, last dose prior sae 30/may/2012
Indication: Breast Cancer
Start date: 2012-03-12
Herceptin
Dosage: last dose prior to sae 21/may/2012
Indication: Breast Cancer
Start date: 2012-03-12
Herceptin
Dosage: last dose prior to sae 21/may/2012, 366 mg
Lapatinib
Dosage: last dose prior to sae :31/may/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-12
Paclitaxel
Dosage: last dose prior to sae 30/may/2012
Indication: Breast Cancer
Start date: 2012-03-12
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-07
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Diarrhoea, Pyrexia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-02-07
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-02-07
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-07
Paclitaxel
Indication: Breast Cancer
Start date: 2012-02-07
Trastuzumab
Indication: Breast Cancer
Start date: 2012-02-07
Other drugs received by patient: Omeprazole
Possible Paclitaxel side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-02
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 15 mg
Start date: 2012-07-10
Paclitaxel
Dosage: 89 mg
Start date: 2012-07-10
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Escherichia Infection, Asthenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Afinitor
Dosage: unk
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Vicodin; Protonix; Lovenox; Duoneb; Metoprolol Tartrate; Xanax; Benadryl
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-07-27
Patient: female, weighing 92.0 kg (202.4 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 20mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-20
Lapatinib
Dosage: 750mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-20
Paclitaxel
Dosage: 80mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-20
Trastuzumab
Dosage: 8mgk every 3 weeks
Indication: Breast Cancer
Start date: 2012-06-19
Other drugs received by patient: Fenistil; Granisetron Hydrochloride; Ranitidine; Dexamethasone Sodium Phosphate
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Pneumonia, Dyspnoea, Anaemia, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Acute Respiratory Distress Syndrome, Oedema, Hypoxia, Escherichia Infection, Asthenia, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Afinitor
Dosage: unk
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Duoneb; Lovenox; Metoprolol Tartrate; Xanax; Vicodin; Benadryl; Protonix
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-07-26
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-05-07
End date: 2012-07-09
Herceptin
Indication: Breast Cancer
Start date: 2012-05-07
End date: 2012-07-09
Lapatinib
Dosage: 750 milligram;
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-05-07
Paclitaxel
Indication: Breast Cancer
Start date: 2012-05-07
End date: 2012-07-09
Other drugs received by patient: Thyranojod; Acetaminophen
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-07-26
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Diarrhoea, Pyrexia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-02-07
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-02-07
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-07
Paclitaxel
Indication: Breast Cancer
Start date: 2012-02-07
Trastuzumab
Indication: Breast Cancer
Start date: 2012-02-07
Other drugs received by patient: Omeprazole
Possible Paclitaxel side effects in 35 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-18
Patient: 35 year old female
Reactions: Abdominal Pain, Vomiting, Nausea, Diarrhoea, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: auc5, in one hour, intravenous (not otherwise specified)
Indication: Cervix Carcinoma
Cisplatin
Dosage: 40 mg, weekly for 5 doses
Indication: Cervix Carcinoma
Paclitaxel
Dosage: 155 mg/m**2, over 3 hours
Indication: Cervix Carcinoma
Other drugs received by patient: Sodium Chloride; Phenergan; Ranitidine; Serotonin (5ht3) Antagonists; Dexamethasone
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-17
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Dyspnoea, Pneumonia, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Hypoxia, Urosepsis, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Duoneb; Lovenox; Vicodin; Xanax; Metoprolol Tartrate; Benadryl; Protonix
Possible Paclitaxel side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: female, weighing 100.9 kg (222.0 pounds)
Reactions: Escherichia Test Positive, Dysuria, Rhinorrhoea, Culture Urine Positive, Pyrexia, Feeling Abnormal, Constipation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ifosfamide
Dosage: 6600 mg
Paclitaxel
Dosage: 270 mg
Possible Paclitaxel side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: female, weighing 100.9 kg (222.0 pounds)
Reactions: Productive Cough, Blood Pressure Increased, Wheezing, Cystitis Klebsiella, Oropharyngeal Pain, Pyrexia, Respiratory Tract Congestion, Myalgia, Fatigue, Dyspnoea Exertional, Activities of Daily Living Impaired, Impaired Healing
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
G-CSF (Filgrastim, Amgen)
Dosage: 6 mg
Ifosfamide
Dosage: 6600 mg
Paclitaxel
Dosage: 270 mg
Possible Paclitaxel side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: male, weighing 104.0 kg (228.8 pounds)
Reactions: Dehydration, Pyrexia, Blood Sodium Decreased, Decreased Appetite, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 900 mg
Cetuximab (Erbitux) 537 MG
Dosage: 537 mg
Paclitaxel
Dosage: 462 mg
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: two doses held due to anc below 800 on 5/17/2012 and 6/1/2012
Paclitaxel
Dosage: two doses held as anc below 800 on 5/17/2012 and 6/8/2012
Other drugs received by patient: Simvastatin; Ativan; Metformin Hydrochloride; Onglyza; Levothyroxine Sodium; Lisinopril
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-12
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Pneumonia, Dyspnoea, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-18
Afinitor
Dosage: unk
Comparator Trastuzumab
Dosage: 137 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-10
Paclitaxel
Dosage: 142 mg
Indication: Breast Cancer Metastatic
Start date: 2010-12-23
End date: 2011-03-03
Vancomycin
Dosage: 1 g, q12h
Start date: 2011-03-16
Other drugs received by patient: Xanax; Metoprolol Tartrate; Vicodin; Benadryl; Protonix; Duoneb; Lovenox
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-07-11
Patient: female, weighing 92.0 kg (202.4 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 20mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-20
Lapatinib
Dosage: 750mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-20
Paclitaxel
Dosage: 80mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-20
Trastuzumab
Dosage: 8mgk every 3 weeks
Indication: Breast Cancer
Start date: 2012-06-19
Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Fenistil; Ranitidine
Possible Paclitaxel side effects in 67 year old female
Reported by a consumer/non-health professional from Ireland on 2012-07-05
Patient: 67 year old female
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded: Ipilimumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Placebo
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Other drugs received by patient: Magnesium Oxide; Miralax; Multi-Vitamin; Omeprazole; Advair Diskus 100 / 50; Calcium Carbonate; Coumadin; Pristiq; Coumadin; Potassium Chloride; Spiriva; Tramadol HCL; Prednisone; Dexamethasone Sodium Phosphate; Diphenhydramine HCL; Proair HFA
Possible Paclitaxel side effects in 66 year old female
Reported by a physician from United States on 2012-07-02
Patient: 66 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Anaemia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: latest received date:08/mar/2012
Indication: Ovarian Epithelial Cancer
Start date: 2012-02-16
Carboplatin
Dosage: latest received date: 22/may/2012
Indication: Ovarian Epithelial Cancer
Paclitaxel
Dosage: latest received date: 22/may/2012
Indication: Ovarian Epithelial Cancer
Possible Paclitaxel side effects in female
Reported by a individual with unspecified qualification from Hong Kong on 2012-07-02
Patient: female, weighing 65.6 kg (144.3 pounds)
Reactions: Syncope, Pulmonary Tuberculosis, Urinary Tract Infection, Presyncope, Pyrexia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: form: infusion, last date prior to sae:02 aug 2011.
Indication: Ovarian Cancer
Start date: 2011-05-24
End date: 2011-12-01
Carboplatin
Dosage: last date prior to sae:02 aug 2011, dose 6 auc
Indication: Ovarian Cancer
Start date: 2011-05-24
End date: 2011-12-01
Paclitaxel
Dosage: form: infusion, last date prior to sae:02 aug 2011.
Indication: Ovarian Cancer
Start date: 2011-05-24
End date: 2011-12-01
Other drugs received by patient: Lamivudine; Cimetidine; Diclofenac Sodium; Mefenamic Acid; Chloorhexidinedigluconaat; Maxolon; Levofloxacin; Neupogen; Generic Component(s) NOT Known; Gastrocaine; Filgrastim; Pepcidine
Possible Paclitaxel side effects in 74 year old female
Reported by a physician from Japan on 2012-06-29
Patient: 74 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Blood Bilirubin Increased, General Physical Condition Abnormal, Urinary Tract Infection, Nail Avulsion, Febrile Neutropenia, Pancytopenia, Pyrexia, Rash, Haematemesis, Hepatic Encephalopathy, Oedema Peripheral, Duodenal Ulcer Haemorrhage, Stevens-Johnson Syndrome, Cardiac Failure Congestive, Hepatitis Fulminant
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Paclitaxel
Start date: 2010-04-27
End date: 2010-04-27
Paclitaxel
Start date: 2010-05-04
End date: 2010-05-04
Paclitaxel
Indication: Breast Cancer Stage II
Start date: 2010-04-20
End date: 2010-04-20
Taxotere
Dosage: three [**] one [yasu]; cycles 1-11
Indication: Breast Cancer Stage II
Start date: 2010-06-10
End date: 2010-09-08
Trastuzumab
Dosage: dosage unknown and three [**] one [yasu]
Indication: Breast Cancer Stage II
Start date: 2010-04-20
End date: 2010-05-11
Trastuzumab
Start date: 2010-05-27
Other drugs received by patient: Zantac; Allegra; Allegra; Candesartan Cilexetil
Possible Paclitaxel side effects in female
Reported by a physician from France on 2012-06-04
Patient: female
Reactions: Pyrexia, Neutropenia, Radiation Mucositis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Start date: 2012-02-24
End date: 2012-02-24
Paclitaxel
Indication: Breast Cancer
Start date: 2012-02-24
End date: 2012-02-24
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-05-24
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 260mg weekly
Indication: Breast Cancer
Start date: 2012-04-30
Doxorubicin HCL
Dosage: 37mg weekly
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: 520mg every 3 weeks
Indication: Breast Cancer
Start date: 2012-04-30
Lapatinib
Dosage: 750mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-04-30
Paclitaxel
Dosage: 146mg weekly
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Pantoprazole; Loperamide
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-05-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Herpes Simplex, General Physical Health Deterioration, Pyrexia, Cystitis, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: auc-2, last dose prior to sae 24 apr 2012. temporarily interrupted.
Indication: Breast Cancer
Start date: 2012-01-11
End date: 2012-04-30
Doxorubicin Hydrochloride
Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
Indication: Breast Cancer
Start date: 2012-01-11
End date: 2012-04-30
Herceptin
Dosage: last dose prior to sae 10 may 2012.
Indication: Breast Cancer
Start date: 2012-01-11
Lapatinib
Dosage: permanently discontinued.
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-01-11
End date: 2012-03-19
Paclitaxel
Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
Indication: Breast Cancer
Start date: 2012-01-11
End date: 2012-04-30
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-05-22
Patient: female
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-03-21
Doxorubicin HCL
Dosage: 20mgm2 weekly
Indication: Breast Cancer
Start date: 2012-03-21
Lapatinib
Dosage: 500mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-21
Paclitaxel
Dosage: 80mgm2 weekly
Indication: Breast Cancer
Start date: 2012-03-21
Trastuzumab
Dosage: 6mgk every 3 weeks
Indication: Breast Cancer
Start date: 2012-03-21
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-05-17
Patient: female, weighing 76.0 kg (167.2 pounds)
Reactions: General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: last dose prior to sae: 24 apr 2012
Start date: 2012-05-08
Doxorubicin Hydrochloride
Dosage: last dose prior to sae: 24 apr 2012
Indication: Breast Cancer
Start date: 2012-01-24
End date: 2012-02-21
Doxorubicin Hydrochloride
Dosage: last dose prior to sae: 24 apr 2012
Start date: 2012-02-28
End date: 2012-05-02
Herceptin
Dosage: last dose prior to sae: 14 feb 2012
Indication: Breast Cancer
Start date: 2012-01-24
End date: 2012-02-21
Herceptin
Dosage: last dose prior to sae: 17 apr 2012
Start date: 2012-02-28
Lapatinib
Dosage: daily
Start date: 2012-02-28
End date: 2012-05-01
Lapatinib
Dosage: last dose prior to sae: 20 feb 2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-01-24
End date: 2012-02-21
Lapatinib
Dosage: daily
Start date: 2012-05-15
Paclitaxel
Start date: 2012-05-08
Paclitaxel
Start date: 2012-02-28
End date: 2012-05-02
Paclitaxel
Dosage: last dose prior to sae: 24 apr 2012
Indication: Breast Cancer
Start date: 2012-01-24
End date: 2012-02-21
Page 1 Next >>
|
